Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APLNR | P35414 | 1/20 | 0.39 |
| ▸ | ACE | P12821 | 4/20 | 0.39 |
| ▸ | ACE2 | Q9BYF1 | 3/20 | 0.38 |
| ▸ | PRCP | P42785 | 1/20 | 0.38 |
| ▸ | XIAP | P98170 | 2/20 | 0.38 |
| ▸ | MLX | Q9UH92 | 1/20 | 0.38 |
| ▸ | ELANE | P08246 | 4/20 | 0.38 |
| ▸ | CMA1 | P23946 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | BIRC2 | Q13490 | 1/20 | 0.36 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | FAAH | O00519 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23230092 | 1.00 | APLNR (0.39) | APLNRACEACE2PRCPXIAP | |
| SCHEMBL23230093 | 1.00 | APLNR (0.39) | APLNRACEACE2PRCPXIAP | |
| SCHEMBL15813270 | 0.89 | CMA1 (0.43) | APLNRCMA1 | |
| SCHEMBL26932805 | 0.86 | XIAP (0.47) | APLNRACEACE2PRCPXIAP | |
| SCHEMBL26932807 | 0.86 | XIAP (0.47) | APLNRACEACE2PRCPXIAP | |
| SCHEMBL1404290 | 0.85 | ACE (0.41) | ACEXIAPMLXELANECMA1 | |
| SCHEMBL29411315 | 0.85 | XIAP (0.42) | ACEXIAPMLXELANECMA1 | |
| SCHEMBL23229944 | 0.85 | ACE (0.41) | ACEXIAPMLXELANECMA1 | |
| SCHEMBL1404295 | 0.85 | ACE (0.41) | ACEXIAPMLXELANECMA1 | |
| SCHEMBL23230058 | 0.84 | XIAP (0.43) | ACEXIAPMLXELANECMA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025096781-A1 | METHODS AND COMPOSITIONS FOR PROVIDING CUSTOMIZED SKIN REGIMENS | VIBRANT HOLDINGS, LLC (US) | 2025-05-08 | — | — | WO | claimed |
| EP-3703651-B1 | MULTI-FACTOR HAIR GROWTH FORMULATION | SKINQRI LLC (US) | 2024-09-25 | — | — | EP | claimed |
| EP-4429775-A1 | COMPOSITION FOR FOUNDATION IN SPRAY FORM | Quadra Group S.r.l. (IT) | 2024-09-18 | — | — | EP | claimed |
| WO-2023079536-A1 | COMPOSITION FOR FOUNDATION IN SPRAY FORM | QUADRA GROUP S.R.L. (IT) | 2023-05-11 | — | — | WO | claimed |
| CN-113651875-B | Oligopeptide-34 synthesis method | 南京莱昂生物科技有限公司 | 2022-01-28 | — | — | CN | claimed |
| WO-2020018926-A1 | EXOSOME DELIVERY OF SKIN CARE PEPTIDES | INTREXON CORPORATION (US) | 2020-01-23 | — | — | WO | claimed |
| EP-4706611-A2 | A DERMATOLOGIC TREATMENT APPARATUS | IP - Smart Ltd (GB) | 2026-03-11 | — | — | EP | disclosed |
| EP-4228746-B1 | A DERMATOLOGIC TREATMENT APPARATUS | IP SMART LTD (GB) | 2025-12-10 | — | — | EP | disclosed |
| WO-2025215143-A1 | LIPOSOMAL COMPOSITION FOR TOPICAL ADMINISTRATION | EVANIUM HEALTHCARE GMBH (DE) | 2025-10-16 | — | — | WO | disclosed |
| EP-4622671-A1 | NANOPARTICLE DISPERSIONS COMPRISING THERAPEUTIC AGENTS | Morrison, Eric (US) | 2025-10-01 | — | — | EP | disclosed |
| US-20250186636-A1 | PROCESS FOR THE PREPARATION OF STERILE PRODUCTS | CMED AESTHETICS S.p.A. (IT) | 2025-06-12 | — | — | US | disclosed |
| CN-222854454-U | Dermatological treatment device and kit | 益智有限公司 | 2025-05-13 | — | — | CN | disclosed |
| WO-2025096781-A1 | METHODS AND COMPOSITIONS FOR PROVIDING CUSTOMIZED SKIN REGIMENS | VIBRANT HOLDINGS, LLC (US) | 2025-05-08 | — | — | WO | disclosed |
| CN-109096373-B | Synthetic oligopeptides and uses thereof | 江苏亨瑞生物医药科技有限公司 | 2022-06-21 | — | — | CN | disclosed |
| WO-2022079449-A1 | A DERMATOLOGIC TREATMENT APPARATUS | IP - SMART LTD (GB) | 2022-04-21 | — | — | WO | disclosed |
| CN-109206485-B | Oligopeptide for preventing and treating lung cancer metastasis | 山东聚胜生物科技有限公司 | 2022-04-08 | — | — | CN | disclosed |
| CN-113651875-B | Oligopeptide-34 synthesis method | 南京莱昂生物科技有限公司 | 2022-01-28 | — | — | CN | disclosed |
| CN-113651875-B | Oligopeptide-34 synthesis method | 南京莱昂生物科技有限公司 | 2022-01-28 | — | — | CN | disclosed |
| CN-113651875-B | Oligopeptide-34 synthesis method | 南京莱昂生物科技有限公司 | 2022-01-28 | — | — | CN | disclosed |
| WO-2020018926-A1 | EXOSOME DELIVERY OF SKIN CARE PEPTIDES | INTREXON CORPORATION (US) | 2020-01-23 | — | — | WO | disclosed |